Chi Podcasts

Megan Allyse, Ph.D., Assistant Professor, Biomedical Ethics, The Mayo Clinic spoke to CHI to discuss the ethical implications that come with advancing NIPT technology, from informed consent and proper infrastructure to proper education for clinicians. She also speaks on how NIPT can serve the larger field of molecular diagnostics to understand what widespread translation looks like for precision medicine technologies. Dr. Allyse is speaking at the NIPT: What’s Next in Technology Development short course, taking place February 20, 2017 in San Francisco as part of the Molecular Med Tri-Conference. For details, visit http://www.TriConference.com/